Lebenthal Global Advisors’s Elevance Health ELV Stock Holding History

Lebenthal Global Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,257	Closed	-$406K	–	194
2025 Q3	$406K	Sell	1,257 -288	-19%	-$89.6K	0.07%	158
2025 Q2	$601K	Buy	1,545 +238	+18%	+$95.7K	0.11%	124
2025 Q1	$568K	Buy	+1,307	New	+$525K	0.11%	122
2024 Q4	–	Sell	-525	Closed	-$273K	–	199
2024 Q3	$273K	Buy	525 +22	+4%	+$11.8K	0.06%	165
2024 Q2	$273K	Buy	503 +3	+0.6%	+$1.59K	0.06%	161
2024 Q1	$259K	Buy	500 +43	+9%	+$21.4K	0.06%	171
2023 Q4	$216K	Buy	+457	New	+$211K	0.05%	181

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Lebenthal Global Advisors's ELV Position: Q4 2025 in Review

Lebenthal Global Advisors sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,257 shares — an estimated $406K sold.

Lebenthal Global Advisors first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $601K in Q2 2025. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

Lebenthal Global Advisors reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
Lebenthal Global Advisors sold 1,257 Elevance Health shares in Q4 2025, an estimated $406K.
Lebenthal Global Advisors first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
Lebenthal Global Advisors's Elevance Health position peaked at $601K in Q2 2025.
1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Lebenthal Global Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.